The global dermatomyositis drugs market is anticipated to grow at a considerable CAGR during the forecast years. Dermatomyositis is a rare inflammatory disease that causes weakness in muscles and rashes on the skin. The major factors for the growth of the global dermatomyositis drugs market are the increasing demand for dermatomyositis drugs due to the increasing number of dermatomyositis disease patients and several research and development activities for the better treatment of dermatomyositis disease. For instance, in June 2021, Corbus Pharmaceuticals Holdings, Inc. announced the results from their phase 3 study of Lenabasum as a treatment for dermatomyositis. The study found that lenabasum has a beneficial effect in the treatment of dermatomyositis.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/dermatomyositis-drug-market
Furthermore, as per the report published in the Indian Journal of Rheumatology in 2020, juvenile dermatomyositis is chronic inflammatory myopathy similar to dermatomyositis has a wide spectrum of disorders that needed a collaborative international clinical trial to study the evidence-based treatment for dermatomyositis. In addition, there are many other studies done and going on for finding the better treatment of dermatomyositis. According to a study published by SAGE journals in 2020, the initial treatment for dermatomyositis is glucocorticosteroids and immunosuppressants. These drugs offer several benefits including stabilization of the disease, decrease in inflammation, and increase in muscle strength. The several research and development activities coupled with the increasing number of patients suffering from dermatomyositis disease are expected to propel the growth of the global dermatomyositis drugs market.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By End-users
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- AstraZeneca group Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Novartis International AG, Pfizer Inc., and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Dermatomyositis Drugs Market Report Segment
By Type
- Abatacept
- Baricitinib
- Dalazatide
- Immune Globulin
- IMP-8400
By end-users
- Hospitals
- Clinics
- Others (Medial Centers, and Pharmacies)
A full report of Dermatomyositis Drugs Market is available at: https://www.omrglobal.com/industry-reports/dermatomyositis-drug-market
Dermatomyositis Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott
- Bristol Myers Squibb (BMS)
- Corbus Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Idera Pharmaceuticals, Inc.
- Merck Group
- Neovacs
- Octapharma AG
- Takeda Pharmaceuticals Co. Ltd.
- Viatris Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
